肝硬化并发门静脉血栓临床表现和诊断进展

doi:10.3969/j.issn.1672-5069.2019.06.002

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (6): 765-767.doi: 10.3969/j.issn.1672-5069.2019.06.002

肝硬化并发门静脉血栓临床表现和诊断进展

庄莹, 林志辉

350001 福州市福建省立医院消化内科/福建省胃肠病研究所

收稿日期:2019-09-02 出版日期:2019-11-13 发布日期:2019-11-13
通讯作者: 林志辉,E-mail:422459214@qq.com
作者简介:庄莹,女,30岁。E-mail:zhuangyingn_n@126.com

Clinical manifestations and diagnosis of portal vein thrombosis

Zhuang Ying, Lin Zhihui.

Department of Gastroenterology, Provincial Hospital,Fuzhou 350001,Fujian Province, ChinaYwzy

Received:2019-09-02 Online:2019-11-13 Published:2019-11-13

摘要/Abstract

关键词: 肝硬化, 门静脉血栓, 门静脉高压

Key words: Liver cirrhosis, Portal vein thrombosis, Portal hypertension

庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.

Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis[J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.

[1] 苟园园,何松,吴开玲,等.肝硬化门静脉血栓160例的临床特点和治疗分析.中华消化杂志,2018,38(7):455-460.
[2] Tsochatzis EA, Senzolo M, Germani G, et al.Portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther, 2010,31:366-374.
[3] Rajani R, Bj rnsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther, 2010,32:1154-1162.
[4] Yerdel MA, Gunson B, Mirza D, et al.Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation, 2000,69:1873-1881.
[5] de Franchis R, Baveno VI. Faculty expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension. J Hepatol, 2015,63:743-752.
[6] Sarin SK, Philips CA, Kamath PS.et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis. Gastroenterology, 2016,151:574-7.e3.
[7] Trebicka J, Strassburg CP.Etiology and complications of portal vein thrombosis. Viszeralmedizin,2014 , 30(6): 375-380.
[8] Kinjo N, Kawanaka H, Akahoshi T, et al.Portal vein thrombosis in liver cirrhosis. World J Hepatol, 2014,6:64-71.
[9] DeLeve LD,Valla DC,Garcia Tsao G. Vascular disorders of the liver.Hepatology,2009,49:1729-1764.
[10] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: vascular diseases of the liver. J Hepatol, 2016,64:179-202.
[11] Hoekstra J, Janssen HL.Vascular liver disorders (II): portal vein thrombosis. Neth J Med, 2009,67:46-53.
[12] Sogaard KK, Astrup LB, Vilstrup H, et al.Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol, 2007,7:34.
[13] Plessier A, Rautou PE, Valla DC.Management of hepatic vascular diseases. J Hepatol, 2012,56(suppl 1):S25-38.
[14] Dell'Era A, Iannuzzi F, Fabris FM, et al. Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation. Dig Liver Dis, 2014,46:152-156.
[15] Dhiman RK, Behera A, Chawla YK, et al.Portal hypertensive biliopathy. Gut, 2007,56:1001-1008.
[16] Amitrano L, Guardascione MA, Brancaccio V, et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol, 2004,40:736-741.
[17] Nery F, Chevret S, Condat B.et al.Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatol Baltim Md, 2015,61:660-667.
[18] Chawla YK, Bodh V.Portal vein thrombosis. J Clin Exp Hepatol,2015,5:22-40.
[19] Berry K, Taylor J, Liou IW, et al.Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. Clin Gastroenterol Hepatol, 2015,13:585-593.
[20] Maruyama H, Okugawa H, Takahashi M, et al.De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol, 2013,108:568-574.
[21] Luca A, Caruso S, Milazzo M, et al.Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology, 2012,265:124-132.
[22] Qi X, Yang Z, Fan D.Spontaneous resolution of portal vein thrombosis in cirrhosis:where do we stand, and where will we go Saudi J Gastroenterol, 2014,20:265-266.
[23] Qi X, Bai M, Yang Z, et al.Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis. Med Hypotheses, 2011,76:522-526.
[24] Ghabril M, Agarwal S, Lacerda M.et al.Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients. Transplantation, 2016,100:126-133.
[25] Chen H, Trilok G, Wang F, et al.A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Indian J Med Res, 2014,139:260-266.
[26] Amitrano L, Brancaccio V, Guardascione MA, et al.Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients:role of genetic thrombophilia. Endoscopy, 2002,34:535-538.
[27] European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol, 2016, 64(1):179-202.
[28] Berzigotti A, Garcia-Criado A., Darnell A.Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol, 2014,11:308-316.
[29] Rossi S, Rosa L, Ravetta V.et al.Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. AJR, 2006,186:763-773.
[30] Qi X,Han G,He C,et a1.CT features of non-malignant ponal vein thrombosis:A pictorial review.Clin Res Hepatol Gastroenterol,2012,36(6):561-568.

肝硬化并发门静脉血栓临床表现和诊断进展

Clinical manifestations and diagnosis of portal vein thrombosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈帅, 杨长青. 门静脉血栓病因及危险因素研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 761-764.
[2]	鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.
[3]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[4]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[5]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[6]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[7]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[8]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[9]	王月圆, 王燕, 张丹丹. 奥曲肽辅助特利加压素治疗失代偿期肝硬化并发肝肾综合征患者疗效分析*[J]. 实用肝脏病杂志, 2019, 22(5): 684-687.
[10]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.
[11]	丹珠永吉, 刘芝兰, 禄艳艳, 蒋汉梅. 内镜下序贯套扎和硬化剂治疗肝硬化并发食管胃底静脉曲张破裂出血患者疗效及对血流动力学的影响对比研究*[J]. 实用肝脏病杂志, 2019, 22(5): 692-695.
[12]	黄汉军, 鲁凤荣, 张灿. 基于Exchange血流动力学模型的MRI扫描参数诊断肝硬化临床价值分析*[J]. 实用肝脏病杂志, 2019, 22(5): 696-699.
[13]	赵芳芳, 翟永贞, 冯国和. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者疗效及安全性分析[J]. 实用肝脏病杂志, 2019, 22(5): 700-703.
[14]	陈山, 庄华帅, 邢诒喜, 吴直佳. 美罗培南治疗肝硬化并发上消化道出血患者对感染预防和再出血的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 704-707.
[15]	徐祺林, 郝少欢, 冉博. 肝硬化脾切除术后门静脉系统血栓形成的危险因素分析*[J]. 实用肝脏病杂志, 2019, 22(5): 708-711.